These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 20512462)
1. Synthesis and in Vitro cytotoxic activities of 2-alkyl-2,3-dihydro-1H-2,6-diazacyclopenta[b]anthracene-5,10-diones. Kwak JH; Namgoong K; Jung JK; Han SB; Cho J; Kim HM; Park SG; Lee K; Kang JS; Lee H Arch Pharm Res; 2010 May; 33(5):663-7. PubMed ID: 20512462 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and cytotoxic activities of 2-alkyl-2,3-dihydro-1H-2,6,9-triazacyclopenta[b]anthracene-5,10-diones. Kwak JH; Namgoong K; Jung JK; Cho J; Kim HM; Park SG; Yoo YA; Kwon JH; Lee H Arch Pharm Res; 2008 Aug; 31(8):995-8. PubMed ID: 18787787 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and cytotoxicity evaluation of 6,11-dihydro-pyridazo- and 6,11-dihydro-pyrido[2,3-b]phenazine-6,11-diones. Lee HJ; Kim JS; Park SY; Suh ME; Kim HJ; Seo EK; Lee CO Bioorg Med Chem; 2004 Apr; 12(7):1623-8. PubMed ID: 15028255 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and cytotoxicity evaluation of substituted pyridazino[4,5-b]phenazine-5,12-diones and tri/tetra-azabenzofluorene-5,6-diones. Lee HJ; Kim JS; Suh ME; Park HJ; Lee SK; Rhee HK; Kim HJ; Seo EK; Kim C; Lee CO; Park Choo HY Eur J Med Chem; 2007 Feb; 42(2):168-74. PubMed ID: 17070967 [TBL] [Abstract][Full Text] [Related]
5. 1,4-disubstituted anthracene antitumor agents. Iyengar BS; Dorr RT; Alberts DS; Sólyom AM; Krutzsch M; Remers WA J Med Chem; 1997 Nov; 40(23):3734-8. PubMed ID: 9371238 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and cytotoxic activities of 8-alkyl or 8-aryl-8,9-dihydro-7H-isoindolo[5,6-g]quinoxaline-7,9-diones. Jung JK; Jung EK; Nam-Goong K; Cho JS; Kim HM; Park SG; Yoo YA; Kwon JH; Lee HS Arch Pharm Res; 2006 Apr; 29(4):276-81. PubMed ID: 16681031 [TBL] [Abstract][Full Text] [Related]
7. 8,11-dihydroxy-6-[(aminoalkyl)amino]-7H-benzo[e]perimidin-7-ones with activity in multidrug-resistant cell lines: synthesis and antitumor evaluation. Stefańska B; Dzieduszycka M; Bontemps-Gracz MM; Borowski E; Martelli S; Supino R; Pratesi G; De Cesare M; Zunino F; Kuśnierczyk H; Radzikowski C J Med Chem; 1999 Sep; 42(18):3494-501. PubMed ID: 10479282 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of imidazol-2-one derivatives as potential antitumor agents. Xue N; Yang X; Wu R; Chen J; He Q; Yang B; Lu X; Hu Y Bioorg Med Chem; 2008 Mar; 16(5):2550-7. PubMed ID: 18226907 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and quantitative structure-activity relationship of cytotoxic gamma-carboline derivatives. Chen J; Dong X; Liu T; Lou J; Jiang C; Huang W; He Q; Yang B; Hu Y Bioorg Med Chem; 2009 May; 17(9):3324-31. PubMed ID: 19359185 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of (Z)-2,3-diphenylacrylonitrile analogs as anti-cancer and anti-microbial agents. Alam MS; Nam YJ; Lee DU Eur J Med Chem; 2013 Nov; 69():790-7. PubMed ID: 24113364 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and cytotoxic evaluation of novel spirohydantoin derivatives of the dihydrothieno[2,3-b]naphtho-4,9-dione system. Gomez-Monterrey I; Santelli G; Campiglia P; Califano D; Falasconi F; Pisano C; Vesci L; Lama T; Grieco P; Novellino E J Med Chem; 2005 Feb; 48(4):1152-7. PubMed ID: 15715481 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and in-vitro antitumor activities of some mannich bases of 9-alkyl-1,2,3,4-tetrahydrocarbazole-1-ones. Chen J; Lou J; Liu T; Wu R; Dong X; He Q; Yang B; Hu Y Arch Pharm (Weinheim); 2009 Mar; 342(3):165-72. PubMed ID: 19212985 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro. Bazargan L; Fouladdel S; Shafiee A; Amini M; Ghaffari SM; Azizi E Cell Biol Toxicol; 2008 Apr; 24(2):165-74. PubMed ID: 17805981 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel thiazolyl-pyrimidines and their anticancer activity in vitro. Shi HB; Li HB; Lu KQ; Zhu XR; Hu WX; Pei W Arch Pharm (Weinheim); 2011 Oct; 344(10):675-83. PubMed ID: 21984017 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vitro-anticancer and antimicrobial evaluation of some novel quinoxalines derived from 3-phenylquinoxaline-2(1H)-thione. El-Hawash SA; Wahab AE Arch Pharm (Weinheim); 2006 Aug; 339(8):437-47. PubMed ID: 16881038 [TBL] [Abstract][Full Text] [Related]
16. Regioselective synthesis of dispiro[1H-indene-2,3'-pyrrolidine-2',3''-[3H]indole]-1,2''(1''H)-diones of potential anti-tumor properties. Girgis AS Eur J Med Chem; 2009 Jan; 44(1):91-100. PubMed ID: 18455272 [TBL] [Abstract][Full Text] [Related]
17. 2,3-Dihydro-1H,7H-pyrimido[5,6,1-de]acridine-1,3,7-trione derivatives, a class of cytotoxic agents active on multidrug-resistant cell lines: synthesis, biological evaluation, and structure-activity relationships. Antonini I; Polucci P; Kelland LR; Menta E; Pescalli N; Martelli S J Med Chem; 1999 Jul; 42(14):2535-41. PubMed ID: 10411474 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and characterization of platinum(II) oxadiazoline complexes and their in vitro antitumor activity in platinum-sensitive and -resistant cancer cell lines. Coley HM; Sarju J; Wagner G J Med Chem; 2008 Jan; 51(1):135-41. PubMed ID: 18072719 [TBL] [Abstract][Full Text] [Related]
19. Cytotoxic N-(fluorenyl-9-methoxycarbonyl) (Fmoc)-dipeptides: structure-activity relationships and synergistic studies. Yen CT; Wu CC; Lee JC; Chen SL; Morris-Natschke SL; Hsieh PW; Wu YC Eur J Med Chem; 2010 Jun; 45(6):2494-502. PubMed ID: 20334960 [TBL] [Abstract][Full Text] [Related]
20. 2,3-Disubstituted 8-arylamino-3H-imidazo[4,5-g]quinazolines: a novel class of antitumor agents. Zhang Y; Chen Z; Lou Y; Yu Y Eur J Med Chem; 2009 Jan; 44(1):448-52. PubMed ID: 18313807 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]